The Wegovy® entries that reach the mouth
We searched the three Wegovy® documents for teeth, dental, caries, gums and saliva. Nothing appears as a reaction in adults, adolescents or post-marketing lists. [1][2][3] The rows below are the reactions dental reviewers point to when they discuss acid exposure.
| Reaction and population | Source | Wegovy® | Placebo |
|---|---|---|---|
| Vomiting, adults, 68 weeks | US Table 3 [1] | 24% | 6% |
| Vomiting, adolescents | US Table 5 [1] | 36% | 10% |
| Vomiting, 7.2 mg trials | US Table 4 [1] | 22% (7.2 mg); 16% (2.4 mg) | 6% |
| Gastro-oesophageal reflux disease, adults | Canadian Table 4 [3] | 5.4% | 3.0% |
| Burping, adults | Canadian Table 4 [3] | 7.4% | 0.4% |
| Dental problems of any kind | US, EU and Canadian documents [1][2][3] | Not listed | — |
What dental research can and cannot say
A 2026 critical appraisal in the Journal of Dental Research reviewed the evidence across dental fields. It described tooth erosion and secondary decay from nausea, vomiting and reflux as a plausible but unquantified risk, and reported that pharmacovigilance analyses have linked semaglutide in particular to dry mouth, taste change and loss of smell. Its central finding was a gap: no prospective study had used any dental outcome as an endpoint in people on GLP-1 medicines. [4]
On gums, the picture is more hopeful but thin. A 2025 review found ten laboratory studies, nine animal studies and one clinical study. In cell and animal work, GLP-1 medicines reduced gum inflammation and bone loss and helped implants bond to bone. The single human study, a retrospective cohort of people with inflammation around implants, found less bone loss in those on GLP-1 medicines than in those on insulin or metformin. [5] None of this involved Wegovy® specifically, and none of it shows that Wegovy® protects the gums.
How Wegovy® could affect teeth
- Acid from below (label-supported reactions, unmeasured dental effect): vomiting, reflux and burping are all more common on Wegovy®, [1][3] and repeated acid contact is how enamel loses minerals. [7]
- Less saliva (proposed): saliva helps enamel repair itself with minerals, [7] and dental reviewers list dry mouth among reported oral effects of semaglutide. [4] Wegovy® documents do not list dry mouth.
- Eating pattern (general): NIDCR links frequent exposure to sugars and starches with decay. [7] Many people eat smaller, more frequent meals on Wegovy®; what those snacks contain matters more than the medicine itself.
- Timing: the label says stomach reactions were most frequent during dose escalation, [1] so any extra acid exposure is likely to cluster in those months.
Dental problems that have nothing to do with Wegovy®
NIDCR explains that decay starts when mouth bacteria turn sugars and starches into acid, and that early decay often has no symptoms; later it can cause toothache, sensitivity to sweets, heat or cold, and, with infection, swelling and fever. [7] Older adults with receding gums can develop decay on exposed roots. [7]
For gum disease, NIDCR names smoking or tobacco use as the most significant risk factor, notes that it is more common and severe in men, and lists diabetes among conditions that contribute. [8] Its signs include red, swollen or bleeding gums, gums pulling away from teeth, loose or sensitive teeth, pain when chewing and persistent bad breath. [8] Many of these risks are already present when someone starts Wegovy®.
Before dental work: the sedation warning
Section 5.10 of the Wegovy® label describes rare reports of food or liquid entering the lungs in people on GLP-1 medicines who had general anaesthesia or deep sedation for planned procedures, despite following fasting instructions. It states that the data are not enough to say whether changing fasting rules or pausing Wegovy® would help, and asks patients to tell their providers about Wegovy® before any planned procedure. [1] MedlinePlus applies the same point to dental surgery. [6]
Most routine dental care uses local anaesthetic, which this warning does not address. If sedation is planned, for example for wisdom teeth or implant surgery, mention Wegovy® early so the dental team and your prescriber can plan together. [1][6]
What dental guidance suggests
NIDCR’s prevention steps are fluoride toothpaste twice a day, cleaning between teeth, fluoridated water or a fluoride rinse, limiting sugary drinks and foods high in sugars and starches, not using tobacco, and regular dental check-ups and cleanings. [7] For gums, it adds that early gum disease can often be reversed with daily brushing and flossing. [8]
The Wegovy® documents do not say how to care for teeth after vomiting. Ask your dentist what suits you, and tell your prescriber if vomiting keeps happening, since the label also links it to dehydration and kidney problems. [1]
Wegovy® is a registered trademark of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.
When to get help
| Sign | Who to contact | How fast | Source |
|---|---|---|---|
| Facial swelling with tooth pain and fever | Your dentist promptly | Today | NIDCR [7] |
| Vomiting that keeps happening or will not settle | Your prescriber | Today | Label §5.6 and §17 [1] |
| Dental surgery or any procedure with sedation or general anaesthesia coming up | Tell your dentist and prescriber beforehand | At your next appointment | Label §5.10 [1]; MedlinePlus [6] |
| New tooth sensitivity, toothache, or bleeding or receding gums | Your dentist | At your next appointment | NIDCR [7][8] |
| Teenager on Wegovy® with frequent vomiting | Their prescriber and dentist | At your next appointment | Label Table 5 [1]; Werner 2026 [4] |
